Skip to main content

MKS Inc. Reports Second Quarter 2026 Financial Results

Revenue of $1,248 million, above the high end of guidance GAAP net income of $175 million and net income per diluted share of $2.41, each above the high end of guidance Adjusted EBITDA of $358 million and Non-GAAP net earnings per diluted share of $3.30, each above the high end of guidanceANDOVER, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) — MKS Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today reported its financial results for the second quarter of 2026. “MKS delivered accelerated double-digit year-over-year revenue growth across each of our end markets in the second quarter, demonstrating our foundational role as an enabler of advanced electronics,” said John T.C. Lee, President and Chief Executive Officer. “As AI-driven investment levels intensify across semiconductor and advanced...

Continue reading

STERIS Announces Financial Results for Fiscal 2027 First Quarter

Fiscal 2027 first quarter revenue increased 7%; constant currency organic revenue growth was 6%  Fiscal 2027 first quarter as reported diluted EPS increased to $2.04; adjusted EPS per diluted share increased to $2.59 Targeted restructuring plan announced associated with new Formulated Chemistries Center of Excellence in North CarolinaDUBLIN, IRELAND, Aug. 05, 2026 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2027 first quarter ended June 30, 2026. Total revenue for the first quarter of fiscal 2027 increased 7% to $1.5 billion compared with $1.4 billion in the first quarter of fiscal 2026. Constant currency organic revenue growth was 6% in the first quarter. “We are pleased with our performance in the first quarter,” said Dan Carestio, President and CEO...

Continue reading

Host Hotels & Resorts, Inc. Reports Results for the Second Quarter of 2026

Delivered Comparable Hotel RevPAR Growth of 7.0% and Comparable Hotel Total RevPAR Growth of 5.9% Raises Full Year 2026 Comparable Hotel Total RevPAR and RevPAR Growth Guidance Ranges to 4.75% to 5.25% BETHESDA, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) — Host Hotels & Resorts, Inc. (NASDAQ: HST) (the “Company”), the nation’s largest lodging real estate investment trust (“REIT”), today announced results for the second quarter of 2026. OPERATING RESULTS(unaudited, in millions, except per share and hotel statistics)                     Quarter endedJune 30,       Year-to-date ended June 30,      2026   2025   Percent Change   2026   2025   Percent ChangeRevenues $ 1,640     $ 1,586     3.4 %   $ 3,285     $ 3,180     3.3 %Comparable hotel revenues⁽¹⁾   1,558       1,471     5.9 %     3,102       2,945     5.3 %Comparable...

Continue reading

Star Group, L.P. Reports Fiscal 2026 Third Quarter Results

STAMFORD, Conn., Aug. 05, 2026 (GLOBE NEWSWIRE) — Star Group, L.P. (the “Company” or “Star”) (NYSE:SGU), a home energy distributor and services provider, today filed its quarterly report on Form 10-Q with the SEC and announced financial results for the fiscal 2026 third quarter, the three months ended June 30, 2026. Three Months Ended June 30, 2026 Compared to the Three Months Ended June 30, 2025For the fiscal 2026 third quarter, Star reported a 17.2 percent increase in total revenue to $358.1 million compared with $305.6 million in the prior-year period, reflecting an increase in average selling prices, driven by higher wholesale product cost. The amount of home heating oil and propane sold during the fiscal 2026 third quarter declined by 3.4 million gallons, or 9.4 percent, to 32.8 million gallons, as...

Continue reading

HMH Holding Inc. Announces Second Quarter 2026 Results

HOUSTON, Aug. 05, 2026 (GLOBE NEWSWIRE) — HMH Holding Inc. (“HMH” or the “Company”) (NASDAQ: HMH) today announced financial and operational results for the second quarter of 2026. Second Quarter HighlightsRevenue of $170.8 million, down 16% compared to the second quarter of 2025 and substantially flat compared to the first quarter of 2026. Net income attributable to HMH of $5.0 million, compared to net income of $8.9 million in the second quarter of 2025 and net income of $3.4 million in the first quarter of 2026. Net income in the second quarter of 2026 reflected a one-time pre-IPO stock-based compensation award expense recognized upon completion of the IPO. Orders of $205 million, up 19% compared to the second quarter of 2025 and down 6% compared to the first quarter of 2026, resulting in book-to-bill of 1.2x. Adjusted EBITDA...

Continue reading

Montauk Renewables Announces Second Quarter 2026 Results

PITTSBURGH, Aug. 05, 2026 (GLOBE NEWSWIRE) — Montauk Renewables, Inc. (“Montauk” or “the Company”) (NASDAQ: MNTK), a renewable energy company specializing in the management, recovery, and conversion of biogas into renewable natural gas (“RNG”), today announced financial results for the second quarter ended June 30, 2026. Second Quarter Highlights:Revenues of $54.0 million, increased 19.7 % year-over-year Net income of $0.2 million, increased 104.1% year-over-year Non-GAAP Adjusted EBITDA of $12.3 million, increased 144.5% year-over-year RNG production of 1.5 million MMBtu, increased 3% year-over-year RINs from operations sold of 14.3 million, increased 29.1% year-over-yearIn July 2026, we began generating power for sale from our Turkey, North Carolina facility. This production of power is expected to be eligible to generate...

Continue reading

NN, Inc. Reports Second Quarter 2026 Results

NN Delivers Strong Second Quarter, Raises Outlook for 2026, Announces Refinancing 5 Pillar Growth Program Delivering Above Expectations; Data Center and Earnings Growing FastCHARLOTTE, N.C., Aug. 05, 2026 (GLOBE NEWSWIRE) —  NN, Inc. (NASDAQ: NNBR) (“NN” or the “Company”), a global diversified industrial company that engineers and manufactures high-precision components and assemblies, today reported results for the second quarter ended June 30, 2026. Q2 2026 Financial Highlights, compared to Q2 2025Net sales of $128.7 million, up $20.8 million or 19.3% Gross margin of $21.9 million, up $3.7 million or 20.1% Adjusted gross margin of $26.1 million, up $5.0 million or 23.9% Adjusted gross margin percentage of 20.3%, up 80 basis points Income from operations $1.0 million, up $2.5 million from a loss of $1.5 million Adjusted income...

Continue reading

BioAge Labs Reports Second Quarter 2026 Financial Results and Provides Business Updates

First participant dosed in QUELL-CV, a Phase 2 dose-ranging proof-of-concept trial of BGE-102 measuring inflammatory and cardiometabolic biomarkers; topline data anticipated in the second half of 2026 QUELL-DME, Phase 1b/2a proof-of-concept trial of BGE-102 in diabetic macular edema, planned to initiate in mid-2026, with data anticipated in mid-2027; results expected to support development across inflammation-driven retinal diseases Hosted R&D Day focused on NLRP3 inhibition, featuring Phase 1 data for BGE-102 EMERYVILLE, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) — BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge” or “the Company”), a clinical-stage biopharmaceutical company developing therapeutic product candidates for cardiometabolic diseases by targeting the biology of human aging, today provided business...

Continue reading

ATN International, Inc. Reports Second Quarter 2026 Results; Announces Increased Repurchase Authorization; and Reaffirms 2026 Outlook

Delivers year-over-year revenue growth of 2% and Adjusted EBITDA1 growth of 9% Receives $268 million in cash at the initial closing of the US Tower Portfolio Sale4 Increases share repurchase authorization to $30 million BEVERLY, Mass., Aug. 05, 2026 (GLOBE NEWSWIRE) — ATN International, Inc. (“ATN,” the “Company,” “we,” “us,” and “our”) (Nasdaq: ATNI), a leading provider of digital infrastructure and communications services, today reported financial results for the second quarter ended June 30, 2026. ATN’s management will host a conference call and webcast tomorrow, August 6, 2026, beginning at 11:00 a.m. Eastern Time to review these results. “Our second quarter results demonstrate the continued strength and resilience of our business. We delivered growth in both total revenue and Adjusted EBITDA, with profitability outpacing sales...

Continue reading

National Healthcare Properties Reports Second Quarter 2026 Results

 SHOP Same Store Cash NOI increased 20.1% on a year-over-year basis  $400 million of 2026 SHOP acquisitions completed or under definitive agreement Secured an additional $650 million of credit facility commitments at improved spreads and terms  Transformed net leverage profile with successful IPO  Appointed Albert M. Campbell to Board of Directors, including its audit committee  NEW YORK, Aug. 05, 2026 (GLOBE NEWSWIRE) — National Healthcare Properties, Inc. (Nasdaq: NHP) (the “Company”), a self-managed real estate investment trust focused on acquiring, owning and investing in a diversified portfolio of healthcare real estate, with an emphasis on providing senior housing to serve a growing elderly population in the United States, today announced results for the quarter ended June 30, 2026. Michael Anderson, Chief Executive Officer...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.